Literature DB >> 20388885

New oversight put in place for physicians giving anemia drugs to patients with cancer.

Mike Mitka.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20388885     DOI: 10.1001/jama.2010.359

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  Physician characteristics and variability of erythropoiesis-stimulating agent use among Medicare patients with cancer.

Authors:  Jason D Wright; Alfred I Neugut; Elizabeth T Wilde; Donna L Buono; Jennifer Malin; Wei Y Tsai; Dawn L Hershman
Journal:  J Clin Oncol       Date:  2011-08-01       Impact factor: 44.544

2.  Effects of the US Food and Drug Administration Boxed Warning of Erythropoietin-Stimulating Agents on Utilization and Adverse Outcome.

Authors:  John Bian; Brian Chen; Dawn L Hershman; Norman Marks; LeAnn Norris; Richard Schulz; Charles L Bennett
Journal:  J Clin Oncol       Date:  2017-04-25       Impact factor: 44.544

3.  Erythropoiesis-stimulating agent use after changes in medicare reimbursement policies.

Authors:  Dawn L Hershman; Alfred I Neugut; Jin Joo Shim; Sherry Glied; Wei-Yann Tsai; Jason D Wright
Journal:  J Oncol Pract       Date:  2014-04-15       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.